Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$742,843
+$134,827 QoQ
Shares Held
30,849
+42.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,499
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $41,817,560 across 12 Drug Manufacturers - General names. PFE ranks #5 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
113,724 | $28,882,484 | |
| 2 | ABBV |
AbbVie Inc.
|
21,140 | $5,319,669 | |
| 3 | LLY |
ELI LILLY & Co
|
3,599 | $4,316,748 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,886 | $1,141,851 | |
| 5 | PFE |
Pfizer Inc
This page
|
30,849 | $742,843 | |
| 6 | AMGN |
Amgen Inc
|
1,750 | $633,710 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,641 | $267,414 | |
| 8 | GSK |
GSK plc
|
4,548 | $238,406 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $742,843 | 30,849 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $608,016 | 21,653 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $599,069 | 24,059 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $815,946 | 32,023 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $615,671 | 25,399 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $625,112 | 24,669 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $792,238 | 29,862 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $696,470 | 24,066 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $754,564 | 26,968 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,053,029 | 37,947 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $1,243,929 | 43,207 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $1,691,139 | 50,984 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $1,880,106 | 51,257 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $1,879,207 | 46,059 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $2,229,554 | 43,512 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $1,923,383 | 43,953 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $2,757,136 | 52,587 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $2,436,969 | 47,073 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $2,785,506 | 47,172 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $2,099,447 | 48,813 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $1,804,375 | 46,077 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $1,630,241 | 44,997 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $1,552,351 | 42,172 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $1,528,516 | 41,649 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $1,206,173 | 36,886 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $563,724 | 17,271 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||